Maryland 2023 Regular Session

Maryland Senate Bill SB622

Introduced
2/6/23  
Refer
2/6/23  
Report Pass
3/16/23  
Engrossed
3/17/23  
Refer
3/20/23  
Report Pass
4/5/23  
Enrolled
4/7/23  
Chaptered
5/16/23  

Caption

Medicaid Waiver Programs – Waitlist and Registry Reduction (End the Wait Act)

Impact

The bill is expected to have a profound impact on state laws governing Medicaid operations. By shifting a portion of Medicaid funding toward enhancing community services and expanding provider capacity, the legislation not only addresses the immediate needs of those on waitlists but also serves as a catalyst for restructuring how waiver programs operate. The introduction of new measures to recruit and retain providers is aimed at improving accessibility and responsiveness within the system, thus facilitating timely support for individuals with disabilities and other qualifying conditions.

Summary

Senate Bill 622, known as the End the Wait Act, introduces significant changes to Medicaid waiver programs in Maryland, specifically aimed at reducing waitlists and enhancing service delivery to individuals awaiting assistance. The bill mandates that the Maryland Department of Health develop plans to achieve a 50% reduction in waitlists for various waiver programs, including the Community Pathways Waiver and the Autism Waiver, by fiscal year 2024. This provision aims to address longstanding delays experienced by eligible individuals and their families who rely on these crucial services.

Sentiment

General sentiment around SB622 appears to be supportive among advocates for individuals with disabilities and healthcare providers. There is wide acknowledgment of the necessity to combat waitlist issues and the potential positive outcomes of enhanced funding for community services. However, concerns have been raised regarding the adequacy of proposed appropriations and the long-term sustainability of the changes. Some stakeholders emphasize the need for ongoing assessments to ensure that capacity expansions keep pace with demands, particularly as the bill's initial goals are underway.

Contention

While the bill has garnered broad support, some points of contention remain. Critics argue that merely reducing waitlists without adequately addressing systemic provider shortages could result in unsustainable pressures on existing service frameworks. Additionally, stakeholders have expressed the urgency for monitoring mechanisms to address and rectify any upcoming challenges should the appropriated funds fall short of what is necessary to effectively implement the bill’s mandates. Hence, while the End the Wait Act represents progress toward better service access, careful execution and ongoing scrutiny will be crucial.

Companion Bills

MD HB1149

Crossfiled Medicaid Waiver Programs - Waitlist and Registry Reduction (End the Wait Act)

Previously Filed As

MD HB1149

Medicaid Waiver Programs - Waitlist and Registry Reduction (End the Wait Act)

Similar Bills

MD HB301

Creation of a State Debt - Maryland Consolidated Capital Bond Loan of 2022, and the Maryland Consolidated Capital Bond Loans of 2014, 2015, 2016, 2017, 2018, 2019, 2020, and 2021

MD HB351

Creation of a State Debt - Maryland Consolidated Capital Bond Loan of 2025, and the Maryland Consolidated Capital Bond Loans of 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, and 2024

MD HB201

Creation of a State Debt – Maryland Consolidated Capital Bond Loan of 2023, and the Maryland Consolidated Capital Bond Loans of 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, and 2022

MD SB320

Creation of a State Debt - Maryland Consolidated Capital Bond Loan of 2025, and the Maryland Consolidated Capital Bond Loans of 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, and 2024

MD SB291

Creation of a State Debt – Maryland Consolidated Capital Bond Loan of 2022, and the Maryland Consolidated Capital Bond Loans of 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, and 2021

MD SB182

Creation of a State Debt - Maryland Consolidated Capital Bond Loan of 2023, and the Maryland Consolidated Capital Bond Loans of 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, and 2022

MD SB361

Creation of a State Debt - Maryland Consolidated Capital Bond Loan of 2024, and the Maryland Consolidated Capital Bond Loans of 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, and 2023

MD HB351

Creation of a State Debt - Maryland Consolidated Capital Bond Loan of 2024, and the Maryland Consolidated Capital Bond Loans of 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, and 2023